Ill. Admin. Code tit. 77, § 2080.230 - Designated Controlled Substances and Other Selected Drugs
For tracking purposes, the Department, upon recommendation of the PMPAC, may designate and list drugs, other substances, and immediate precursors as:
a) A Schedule I if the
Department finds that:
1)
the
substance has high potential for abuse; and
2)
the substance has no currently
accepted medical use in treatment in the United States or lacks accepted safety
for use in treatment under medical supervision [720 ILCS
570/203 ].
b) A Schedule II if the Department finds
that:
1)
the substance has high
potential for abuse;
2)
the substance has currently accepted medical use in treatment in the
United States, or currently accepted medical use with severe restrictions;
and
3)
the abuse
of the substance may lead to severe psychological or physiological
dependence [720 ILCS 570/205 ]
.
c) A
Schedule III if the Department finds that:
1)
the substance has a potential for abuse less than the substances listed
in Schedules I and II;
2)
the substance has currently accepted medical use in treatment in the
United States; and
3)
abuse of the substance may lead to moderate or low physiological
dependence or high psychological dependence [720 ILCS
570/207 ] .
d) A Schedule IV if the Department finds
that:
1)
the substance has a low
potential for abuse relative to substances in Schedule III;
2)
the substance has currently
accepted medical use in treatment in the United States; and
3)
abuse of the substance may lead to
limited physiological dependence or psychological dependence relative to the
substances in Schedule III [720 ILCS
570/209 ] .
e) A Schedule V if the Department finds that:
1)
the substance has low potential
for abuse relative to the controlled substances listed in Schedule
IV;
2)
the
substance has currently accepted medical use in treatment in the United States;
and
3)
abuse of
the substance may lead to limited physiological dependence or psychological
dependence relative to the substances in Schedule IV, or the substance is a
targeted methamphetamine precursor as defined in the Methamphetamine Precursor
Control Act [720 ILCS 648 ]. [720 ILCS
570/211 ]
f) Other Selected Drugs, including:
1) those medications that may contribute to
clinical reviews of scheduled medications;
2) those medications determined to need
additional monitoring or to assist in facilitating medication optimization and
utilization; and
3) the dispensing
of Naloxone for opioid overdose prevention.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.